CTLA-4 Blockade with Monoclonal Antibodies in Patients with Metastatic Cancer: Surgical Issues

被引：0
|
作者：
Giao Q. Phan
Jeffrey S. Weber
Vernon K. Sondak
机构：
[1] H. Lee Moffitt Cancer Center,Division of Cutaneous Oncology
[2] H. Lee Moffitt Cancer Center,The Donald A. Adam Comprehensive Melanoma Research Center
[3] University of South Florida College of Medicine,Department of Oncologic Sciences
[4] University of South Florida College of Medicine,Department of Surgery
来源：
Annals of Surgical Oncology | 2008年 / 15卷
关键词：
Immune-related Adverse Events (IRAEs); Ipilimumab; Tremelimumab; Hypophysitis; Infliximab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3014 / 3021
页数：7
相关论文
共 50 条
  • [41] Combination Immunotherapy with 4-1BBL and CTLA-4 Blockade for the Treatment of Prostate Cancer
    Kuang Youlin
    Zhang Li
    Weng Xiaodong
    Liu Xiuheng
    Zhu Hengchen
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
  • [42] Ibrutinib enhances the antitumor efficacy of CTLA-4 blockade in lymphoma and colon cancer models
    Ng, Patrick
    Lu, Daniel
    Chang, Betty
    CANCER RESEARCH, 2015, 75
  • [43] At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
    Intlekofer, Andrew M.
    Thompson, Craig B.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2013, 94 (01) : 25 - 39
  • [44] Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade
    Shukla, Sachet A.
    Bachireddy, Pavan
    Schilling, Bastian
    Galonska, Christina
    Zhan, Qian
    Bango, Clyde
    Langer, Rupert
    Lee, Patrick C.
    Gusenleitner, Daniel
    Keskin, Derin B.
    Babadi, Mehrtash
    Mohammad, Arman
    Gnirke, Andreas
    Clement, Kendell
    Cartun, Zachary J.
    Van Allen, Eliezer M.
    Miao, Diana
    Huang, Ying
    Snyder, Alexandra
    Merghoub, Taha
    Wolchok, Jedd D.
    Garraway, Levi A.
    Meissner, Alexander
    Weber, Jeffrey S.
    Hacohen, Nir
    Neuberg, Donna
    Potts, Patrick R.
    Murphy, George F.
    Lian, Christine G.
    Schadendorf, Dirk
    Hodi, F. Stephen
    Wu, Catherine J.
    CELL, 2018, 173 (03) : 624 - +
  • [45] Cordycepin synergizes with CTLA-4 blockade to remodel the tumor microenvironment for enhanced cancer immunotherapy
    Chen, Lujun
    Zheng, Xiao
    Huang, Hao
    Feng, Chen
    Wu, Shaoxian
    Chen, Rongzhang
    Jiang, Hongwei
    Yuan, Maoling
    Fu, Yuanyuan
    Ying, Hanjie
    Zhou, Jun
    Jiang, Jingting
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [46] Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth
    Parra, Karla
    Valenzuela, Paloma
    Gallegos, Alejandra E.
    Lerma, Natzidielly
    Reza, Luis
    Rodriguez, Georgialina
    Emmenegger, Urban
    Manciu, Marian
    Di Desidero, Teresa
    Bocci, Guido
    Felder, Mitchell S.
    Kirken, Robert A.
    Francia, Giulio
    CANCER RESEARCH, 2016, 76
  • [47] Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth
    Karla Parra
    Paloma Valenzuela
    Natzidielly Lerma
    Alejandra Gallegos
    Luis C Reza
    Georgialina Rodriguez
    Urban Emmenegger
    Teresa Di Desidero
    Guido Bocci
    Mitchell S Felder
    Marian Manciu
    Robert A Kirken
    Giulio Francia
    British Journal of Cancer, 2017, 116 : 324 - 334
  • [48] Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth
    Parra, Karla
    Valenzuela, Paloma
    Lerma, Natzidielly
    Gallegos, Alejandra
    Reza, Luis C.
    Rodriguez, Georgialina
    Emmenegger, Urban
    Di Desidero, Teresa
    Bocci, Guido
    Felder, Mitchell S.
    Manciu, Marian
    Kirken, Robert A.
    Francia, Giulio
    BRITISH JOURNAL OF CANCER, 2017, 116 (03) : 324 - 334
  • [49] New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient
    Miserocchi, Elisabetta
    Cimminiello, Carolina
    Mazzola, Marco
    Russo, Vincenzo
    Modorati, Giulio M.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2015, 50 (01): : E2 - E4
  • [50] Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
    Fan, Xiaozhou
    Quezada, Sergio A.
    Sepulveda, Manuel A.
    Sharma, Padmanee
    Allison, James P.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (04): : 715 - 725
12345